BTW
MEDP icon

Boston Trust Walden’s Medpace MEDP Stock Holding History

Boston Trust Walden’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.4M Buy
155,517
+14,907
+11% +$6.88M 0.63% 48
2026
Q1 		$67.5M Sell
140,610
-7,391
-5% -$3.78M 0.56% 58
2025
Q4 		$83.1M Sell
148,001
-3,199
-2% -$1.82M 0.63% 45
2025
Q3 		$77.7M Buy
151,200
+126
+0.1% +$55K 0.57% 53
2025
Q2 		$47.4M Buy
151,074
+16,270
+12% +$4.88M 0.34% 122
2025
Q1 		$41.1M Buy
134,804
+229
+0.2% +$77K 0.3% 131
2024
Q4 		$44.7M Buy
134,575
+4,920
+4% +$1.67M 0.31% 130
2024
Q3 		$43.3M Sell
129,655
-28,296
-18% -$10.7M 0.3% 134
2024
Q2 		$65.1M Sell
157,951
-109,064
-41% -$43.2M 0.48% 71
2024
Q1 		$108M Sell
267,015
-221,256
-45% -$77.8M 0.77% 32
2023
Q4 		$150M Sell
488,271
-51,684
-10% -$14M 1.13% 15
2023
Q3 		$131M Sell
539,955
-9,952
-2% -$2.55M 1.1% 15
2023
Q2 		$132M Sell
549,907
-12,728
-2% -$2.64M 1.08% 15
2023
Q1 		$106M Buy
562,635
+15,193
+3% +$3.14M 0.91% 23
2022
Q4 		$116M Sell
547,442
-151,618
-22% -$30.3M 1.02% 16
2022
Q3 		$110M Buy
699,060
+10,282
+1% +$1.64M 1.09% 14
2022
Q2 		$103M Buy
688,778
+13,784
+2% +$2M 0.97% 18
2022
Q1 		$110M Buy
674,994
+186,518
+38% +$30.8M 0.91% 21
2021
Q4 		$106M Sell
488,476
-39,915
-8% -$8.36M 0.85% 25
2021
Q3 		$100M Buy
528,391
+2,164
+0.4% +$395K 0.89% 22
2021
Q2 		$92.9M Sell
526,227
-16,891
-3% -$2.92M 0.83% 24
2021
Q1 		$89.1M Buy
543,118
+33,488
+7% +$5.12M 0.86% 23
2020
Q4 		$70.9M Buy
509,630
+101,346
+25% +$12.8M 0.76% 29
2020
Q3 		$45.6M Buy
408,284
+14,749
+4% +$1.71M 0.57% 50
2020
Q2 		$36.6M Buy
+393,535
New +$33.5M 0.49% 62

Other funds holding MEDP

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

Boston Trust Walden's MEDP Position: Q2 2026 in Review

Boston Trust Walden increased its Medpace (MEDP) stake by 11% in Q2 2026, buying an estimated $6.88M and bringing the position to 155,517 shares worth $82.4M. The position accounts for 0.63% of the portfolio, ranked #48.

Boston Trust Walden first reported a position in MEDP in Q2 2020 and has held it in 25 quarters since. The position peaked at $150M in Q4 2023. 234 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Boston Trust Walden held 155,517 shares of Medpace worth $82.4M as of Q2 2026.
  • Boston Trust Walden bought 14,907 Medpace shares in Q2 2026, an estimated $6.88M.
  • Medpace made up 0.63% of Boston Trust Walden's portfolio in Q2 2026, its #48 holding.
  • Boston Trust Walden first reported a position in Medpace in Q2 2020 and has held it in 25 quarters since.
  • Boston Trust Walden's Medpace position peaked at $150M in Q4 2023.
  • 234 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.